Close your investment round faster

Capital Cell is the world's leading alternative investment platform for biotechnology and life sciences companies.

We are an authorized provider under the European Securities and Markets Authority and under the tax incentive schemes in force.

We select the most promising investment opportunities from across Europe to launch on capitalcell.com, helping them find funds in an agile way so they can focus on developing their businesses.

The investment community of Capital Cell

18.000+
Investors
registered

124
Rounds of
investment

62M€
Directly invested
via crowdfunding

873.000€
Round
media

2.857M€
Average investment
per investor

93,4%
Successfully closed rounds

We have the tools you need for your investment round.

Online platform

More agility and less paperwork for your investors.

Save money

Our standard investment and syndication agreements can save you thousands of euros in lawyers' fees.

Personalized attention

Accompaniment throughout the investment round.

Saves time

Our payment gateway, anti-money laundering controls and legal framework save you valuable time.

Experts and investors

You get quality commentary and testimonials from scientific experts and investors in the BioExpert Network.

Marketing plan

We help you promote your investment round with a marketing plan and improving your pitch.

Visibility platform

Our platform gives visibility to your investment opportunity among investors in the biomedical sector.

Events

We will invite you to our monthly events so that you can personally present your proposal to investors.

 

How much does it cost to raise a round of financing with Capital Cell?

Included in the round free of charge

  • Analysis and report of the BioExpert Network.
  • Crowdfunding consulting and personalized advice.
  • Communication and promotion of the campaign among our network of investors.
  • Strategic financial consulting: round structure, investment objective, valuation, etc.
  • Analysis and report by the consultancy Alira Health.
  • Legal and financial due diligence.
  • Escrow account and payment gateway.

Not included in the round

Publication on the platform
€750

Crowdfunding campaign:

  • Competitive commission on funds raised: 7%.
  • At Capital Cell we do not charge commission for previously agreed investments.

Additional services:

  • Marketing services : Video, PR (press, events), banners, infographics, advertising on social networks and professional networks : 3% of the campaign target
  • Legal services before and after the round: check prices according to your needs

Send us your investment opportunity

Send us your pitch deck and we will evaluate it with our team of experts.

Companies that have already achieved its objectives

Bionure - now Accure Therapeutics - raised €1,200,000 in 2017 and €1,337,000 in 2019 to develop an innovative multiple sclerosis drug.

Vytrus went public through an IPO, giving investors a success with its innovative production of plant cell cultures.

GoodGut's diagnostic and therapeutic technology for digestive diseases continues development and commercialization after its sale to HIPRA.